8/06/2015 - - PDF document

▶
8 06 2015
SMART_READER_LITE
LIVE PREVIEW

8/06/2015 - - PDF document

Nov 15, 2023 433 likes •519 views

8/06/2015

slide-1
SLIDE 1

8/06/2015 1

  • !

"#$%&'()

  • !!

Begg et al The burden of disease and injury in Australia 2003 AIHW 2007

"#$#%

  • * +,(

range of function in individuals

  • genes
  • diet
  • lifestyle

Early Life

Growth and development

Adult Life

Attaining highest level of function

Older Age

Maintaining health and independence

Functional capacity (physical & mental fitness)

WHO/HPS Geneva, 2000

Disability threshold

# &'()*+

  • %-./0

December 13-19, 2003

slide-2
SLIDE 2

8/06/2015 2

,-.

/

  • %

,

  • &
  • !"#

$%

  • !"&

↓ ↓ ↓ ↓. ↑ ↑ ↑ ↑

  • !1223343
  • %'

5

#*$

  • 6

7

  • 8
  • 9

:

  • 6
  • ;

< < < <

1..0 ,.

%. %. %. %. = '%2444 = 4. = .' "!.') = .4 "'.. .4!)

' () *&+, %/2 !-% %/2 !-% %/2 !-% %/2 !-%

  • '

>.' . ??- 4#######@@###A@###

  • !4
  • 0,&
  • ,#

0,& .'.% &,& >### #,& *! >,&Bβ $& ,?B/& >A ,B/& .'!

  • &@

C

  • &
  • ,#2
  • #B-#B

0*&

  • #B#B8#B9

>A2& >D77077 0& ?-B?-B ( ?*## % ? % ,D+/E

  • %
  • .
  • /%

.%%.

  • 1..

*.

  • .)2,&+

%0. 1#0..

..2 .... NO

  • .!%!

Subjects 9 M, 18 F 8 M, 18 F Age (yr) 49.6 ± 1.6 50.1 ± 1.3 0.80 Height (m) 1.69 ± 0.02 1.67 ± 0.02 0.54 Mass (kg) 100.9 ± 3.4 63.0 ± 1.5 <0.001 BMI (kg/m2) 35.3 ± 0.9 22.5 ± 0.3 <0.001 DEXA Body fat (%) 43.5 ± 1.2 27.2 ± 1.6 < 0.001 SBP (mmHg) 127.0 ± 2.6 118.6 ± 3.1 < 0.05 DBP (mmHg) 72.4 ± 2.0 67.0 ± 1.8 < 0.05 Large artery elasticity 16.5 ± 0.9 15.5 ± 0.6 0.36 Small artery elasticity 7.0 ± 0.5 7.3 ± 0.5 0.67 FMD (%) 3.2 ± 0.4 5.7 ± 0.7 < 0.01 C' C' C' C'

  • .12/

0FC'

%.% %

  • 3

%

  • .

1

  • ..
  • .

.3 4 .%

  • .

.

  • 5

5.' 4 .

slide-3
SLIDE 3

8/06/2015 3

6.

>10,000 >6,000

Generic antioxidants ?

  • r

Mediators of specific physiological functions?

Erdman J et al. J Nutr 2007;137:718S

  • !%4(3)&*&&+5&

5

6% 6

2,&*.

7382(7!9/3 &*5+&:

  • .7 (;&
  • 9%7(!!%
  • 2%2)82()
  • < 8(3)=
  • %. → );↑ >7(8?

@ @

  • 5

= # , ? & " ", " .% A. %

  • 465

!6: O OH HO OH OH OH +)-catechin (-)-epicatechin

Regulation of Endothelial Nitric Oxide l-arginine l-arginase NO synthase urea nitric oxide (NO) free radical oxidation NOx

@

  • 5

= # , ? & 465 !6: 687

  • .
  • %

1 2,&

9$B acute FMD responses chronic FMD responses

*!3!"#

1% improvement in FMD = 13% lower risk of future cardiac events >.99.+$

  • >.. 9..9

<7$687.%%7& >. .

7.C(!%

  • .785-6#0!9:5
  • .785&6#0!9:5

1536#$.*

3+$%=.2

72)8 '382(7!9/3(!!%

slide-4
SLIDE 4

8/06/2015 4

1-

!% ! 6

%%,= 9.9. 9 $%

25.-5&

D ,#$?

  • .%%#?=$' ! 9%%.

5 ,,>.. %.99.$% ;%-

$ 7< !

,9=,9E? F%%.9% 99.% 9

4 (<% ?

$ $ $ $

  • ''%
  • '44
  • !!...%
  • '%B''

> G34&%.3 '%''%' %B%!%%( -#6(% %%.4%44..'%3

6..

6.)(3 . , &09 .9$.

5 5

C.(.%.9.% %..

  • 6. 2.

%% 7 !%%%9.

  • 9. &9

5...

29>7%%G>37 C99.83 %

/G 1- D1' 1?%%' ?%%' ?%%' ?%%' 01% 1C!. &1#% ,1-'

1 2,&

.

  • 3<..
  • .

1"α .

  • 3

.. . .

  • 4

1"β 1"α

  • .

1"β 1"α <1"β 1"β

(.-.

1"α <1"β 1"β 4

  • C .687.,9%</β
  • >.</β
  • </β 9. / =
  • < .</α </β 97 H?

"..9. %%, 9.%9

>.%C)2( 3!9 2() :

2 4 6 8 10

69I##

@ @

J# >.%(3)&*&&+:& (!% :*?C%% =+C#5

7CK7C

  • =9:

5/ &3% -. 8H71/

  • 1-

D1' 1?%%' ?%%' ?%%' ?%%' 01% 1C!. &1#% ,1-'

slide-5
SLIDE 5

8/06/2015 5

" "';<

.%%. %.% %9.%.% ) ..%. 9.%.8;$27<= .<<'δ θ ".%$%.C% 3"> 3.) %%,K9.. D=0.6873F/% ....9%

" " 5

  • #
  • #
  • #

5 5#

  • "';<

3F/0

  • =

, &

  • "';<

6870

=% % % %4 4 4 4 /9.6.

  • 3

%

  • 3

% /.

  • %

H

  • %
  • 3
  • $

,*

3..2(3 . A ? 7

"/ /3 !

%4H63 7>. :

/ );C % ); ); <. 3% 3%

1 2 3 4 5 6 7 8 9 10 30 90 270

FMD response (%) Resveratrol dose (mg) +1.9% +2.4% +3.4% +1.5% +2.5% +2.4%

Red wine polyphenol extract (600mg)1 Cocoa flavanols (902mg)2 Tea (450ml)3 EGCG (300mg)4

+3.7%

"2,&

") 8 3 7

1 2 3 4 5 6 7 8 Chronic FMD response

5&0 50 I

@

Placebo Resveratrol

5"

I$=:*#I&

3.6870 L % :..2,&> :3 /"(!% 5

&?0"5)

slide-6
SLIDE 6

8/06/2015 6

Resveratrol Placebo

∆Resveratrol - Placebo

P 95% CI of change d Stroop Word reading trial Time taken (sec) 93.9 ± 5.2 98.9 ± 5.2

  • 4.96 ± 2.89

0.09

  • 10.89

0.96 .662 Uncorrected errors 0.32 ± 0.25 0.57 ± 0.31

  • 0.25 ± 0.12

0.05

  • 0.50

0.00 .789 Corrected errors 0.68 ± 0.27 0.86 ± 0.97

  • 0.18 ± 0.19

0.36

  • 0.57

0.22 .356 Stroop Colour naming trial Time taken (sec) 182.9 ± 7.8 185.0 ± 8.6

  • 2.07 ± 2.75

0.46

  • 7.72

3.58 .289 Uncorrected errors 1.39 ± 0.78 1.07 ± 0.33 0.32 ± 0.61 0.60

  • 0.93

1.57 .202 Corrected errors 3.18 ± 0.59 3.00 ± 0.42 0.18 ± 0.48 0.71

  • 0.81

1.16 .143 <..M9%.99 %9%%9.

%%& %%& %%& %%&

5"

  • /"(!% 5
  • ..$:
  • ##
  • 3+CH/%F
  • 39+6$%%
  • /%9%
  • )

F%0.

". .

!>.N93% ) : 8.9F'G 2 *"- 9% 2 ,".

78!.%4%%( ".42%')!'8.3 ?.%%8.H.%.!!.! %'?#3 ?(4.'...!% %!%4'%3

  • I369
  • I369
  • I369
  • I369
  • J37

J37 J37 J37

  • J37
  • J37
  • J37
  • J37

?. ?. ?. ?.-.

  • .
  • .
  • .%

% % % *!!.!& *!!.!& *!!.!& *!!.!&@$ 7

#.!%.. %%

  • %*'

%%

  • 1%/,*"

1% 5):+

  • '.(>0?

'.(>0? '.(>0? '.(>0?

. 7

>789. > 9%.%

/"3 7 /%=

  • 5)5="+

.&,5&

  • 7

8 9

  • 7

8 9

  • B'(
  • .'

K4 04! '(% 04! % / '

  • !

4( 04.' %4D 04.' %4 /!

  • /!%

5 5 5 5

  • ?

4? 9 9.>%

%"!9

functional TCD

"J) >0?"J:) ? /0 ? /0

  • 4")

83 3 883 3 39 0%'") BBB BBB :38 93 BBB &4*'"5) BBB BBB 83 3: BBB &44"..2) 3 36 36 38 3 &4".#2) 37 3 :39 3 3 *C?B# 37 36 639 3: 3: D?#"(42.) 37 3 :3 39 3: $.".) :73 83: 83 63 3 /'%!"..*4) 3 637 637 83 36 0'%!"..*4) 93 :3 936 3 3:7 ?B?/ ."??/) 93: 3 93 3 3867 ' '%".2)") 683: 39 73 3: 36: ' '%".2)"4) 637 93 73 38 3:

  • #% ")

38 39 3: 3 3:

  • #% "4)

3 3: 3: 3 36

"!.%.$4*)

#..&, '.

slide-7
SLIDE 7

8/06/2015 7

15=".&,

  • 6

6 @"5) @"5) @"5) @"5)

? ? ? ? >0? B>0?

  • 6

6 @"5) @"5) @"5) @"5)

4? 4? 4? 4? *

P<0.05

*

P<0.01

8&,3 5="..*)+

"!.%.$4*)

#(5/.* )1#0 &%+

"

%K .. 9

  • %

%O .O 3;7O

#

$%"&'

  • "()
  • ..

. .

  • 1.<

#. %.% 5%

  • %

% % %

%7!7 %% .B%.OO

/.*,%(

1.*.&%&

  • ?$9.7!%7
  • 3%<$.7!$.4$.%

*+

  • ..7!I9
  • ..$5G6IK.
  • ..$,G6I%%
  • .9.?K?#.97!

83C)2(738N/8!9"

,-

  • 7!%99.

%.%%9.

83C)2(738N/8!9!

/.*,5),$./3>

  • 49<9.83 .

83C)CC2(3!9#',.

  • 2.<7!%%

C)83CC2(3 (!9*!

  • 7!%%%
  • 7!%..$D

9...%

  • ;$5%%.%.9$

""$ /.*4&%&0 &0&.* %&

  • 83C)!9!(:
  • D
  • /.%%%.4

.!44'% !..% .!%4!%.4") %"D)%.%% !.")%"0).3 $4%. $4%. $4%. $4%. !4 !4 !4 !4

#.!@ #.!@ #.!@ #.!@ %.' %.' %.' %.' ( ( ( (

!% , # D%- #.. D%4

↑ ' ' ' ' % % % % & & & & ↑ 4 4 4 4

C% 4 &' @. & ?4.

  • .
  • !

") ,#

  • 5.%*/# 31

5="5

(2/3!9(2(283%.

%*B!"() 9742%.%842%. %

slide-8
SLIDE 8

8/06/2015 8

5.

  • 3

3 36 37 3 38 3 39 ?.

  • @'
  • 4

!%

L L L L

0.! 0.! 0.! 0.! ! ! ! !

5

!I3

L L L L

/.

,% :K5 ,#P 28 5P KQ 2 4 6 8 10 12 14 % Difference in CVR Peanuts vs control

*

Left Right

*

55=" 5

@> 4 @ %%

  • @>

%

  • J3
  • J3
  • J3:

>..3

  • ...

9.% @ @

!1223%!3 .2.42MMM' 2'M. %2'B 63N!4

*4 *4 *4 *4

  • (.!

(.! (.! (.!&?0 &?0 &?0 &?0

  • B

B B B% % % %

0-*! 6

4 3?9

!4%%(E.% 69'N4%O'N...!.%.E% .%!!4."6 .2()PP8.9 .!3 >P4E.0./B 4/'P.!%38 !4!37%PP4!3> .%.!.%%%%0.43 Q333 Q333 Q333 Q333%!%'4% 4%4%444 !.%(%.%E.P%3 0!!.%!!4.%( %.'.%.E%Q3

4 +.%3 C!-8

Q' 4'.!% "&?0)%%@0(%!3Q

/D/!?%/!

' .!%4 ' .!%4 ' .!%4 ' .!%4

5

  • %.$

9..

  • /%$5%%%.

%%...

  • >. .

%.

  • <%D.

%%M% >. %...

  • >.9.%%.

.%..%. % %%